Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.

Chew KK, Ng KY, Khong WX, Kaur P, Yap JK, Chua A, Tan MT, Koh YL, Thoon KC, Leo YS, Ng OT.

Ann Acad Med Singapore. 2012 Dec;41(12):553-8.

2.

Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.

Chen JH, Wong KH, Chan K, Lam HY, Lee SS, Li P, Lee MP, Tsang DN, Zheng BJ, Yuen KY, Yam WC.

J Clin Virol. 2007 Jun;39(2):125-31. Epub 2007 Apr 20.

PMID:
17449318
3.

An in-house HIV genotyping assay for the detection of drug resistance mutations in Southeast Asian patients infected with HIV-1.

Lee CK, Lee HK, Loh TP, Sethi SK, Koay ES, Tang JW.

J Med Virol. 2012 Mar;84(3):394-401. doi: 10.1002/jmv.23202.

PMID:
22246824
4.

Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.

Xu S, Zhong P, Li J, Song A, Li H, Nie J, Li X, Wang Y.

Mol Diagn Ther. 2011 Feb 1;15(1):41-52. doi: 10.2165/11588860-000000000-00000.

PMID:
21469769
5.

Performance comparison of an in-house integrase genotyping assay versus the ViroSeq™ Integra48, and study of HIV-1 integrase polymorphisms in Hong Kong.

To SW, Chen JH, Wong KH, Chan KC, Ng HM, Wu H, Lam JT, Yam WC.

J Clin Virol. 2013 Sep;58(1):299-302. doi: 10.1016/j.jcv.2013.06.040. Epub 2013 Jul 22.

PMID:
23886504
6.

Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.

Chaturbhuj DN, Deshmukh PS, Hingankar NK, Siddhaarth K, Deshpande SN, Sen S, Kabra S, Paranjape RS, Tripathy SP.

J Virol Methods. 2013 Apr;189(1):87-92. doi: 10.1016/j.jviromet.2013.01.001. Epub 2013 Jan 23.

PMID:
23353551
7.

Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.

Zhou Z, Wagar N, DeVos JR, Rottinghaus E, Diallo K, Nguyen DB, Bassey O, Ugbena R, Wadonda-Kabondo N, McConnell MS, Zulu I, Chilima B, Nkengasong J, Yang C.

PLoS One. 2011;6(11):e28184. doi: 10.1371/journal.pone.0028184. Epub 2011 Nov 23.

8.

A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.

Steegen K, Demecheleer E, De Cabooter N, Nges D, Temmerman M, Ndumbe P, Mandaliya K, Plum J, Verhofstede C.

J Virol Methods. 2006 May;133(2):137-45. Epub 2005 Dec 20.

PMID:
16375980
9.

Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.

Couto-Fernandez JC, Silva-de-Jesus C, Veloso VG, Rachid M, Gracie RS, Chequer-Fernandez SL, Oliveira SM, Arakaki-Sanchez D, Chequer PJ, Morgado MG.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):73-8. Epub 2005 Apr 12.

10.

Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong.

Yam WC, Chen JH, Wong KH, Chan K, Cheng VC, Lam HY, Lee SS, Zheng BJ, Yuen KY.

J Clin Virol. 2006 Apr;35(4):454-7. Epub 2005 Dec 28.

PMID:
16386461
11.

Development of a cost-effective assay for genotyping of HIV-1 non-B subtype for drug resistance.

Ammaranond P, Sanguansittianant S, Raju PA, Cunningham P, Horthongkham N.

J Virol Methods. 2014 Apr;199:102-7. doi: 10.1016/j.jviromet.2014.01.007. Epub 2014 Jan 22.

PMID:
24462843
13.

Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon.

Fokam J, Salpini R, Santoro MM, Cento V, D'Arrigo R, Gori C, Perno CF, Colizzi V, Nanfack A, Gwom LC, Cappelli G, Takou D.

Arch Virol. 2011 Jul;156(7):1235-43. doi: 10.1007/s00705-011-0982-3. Epub 2011 Apr 5.

PMID:
21465085
14.

Development, validation and clinical evaluation of a low cost in-house HIV-1 drug resistance genotyping assay for Indian patients.

Acharya A, Vaniawala S, Shah P, Misra RN, Wani M, Mukhopadhyaya PN.

PLoS One. 2014 Aug 26;9(8):e105790. doi: 10.1371/journal.pone.0105790. eCollection 2014.

15.

Human immunodeficiency virus-1 genotypic drug resistance among volunteer blood donors in Yunnan, China.

Tu YQ, Wang MJ, Yao J, Zhu XM, Pan PL, Xing WG, Zhang GH, Yang RG, Zheng YT, Jiang Y.

Transfusion. 2009 Sep;49(9):1865-73. doi: 10.1111/j.1537-2995.2009.02219.x. Epub 2009 May 18.

PMID:
19453981
16.

Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AE.

Dokuta S, Utaipat U, Praparattanapan J, Keitkarn J, Maneekarn N, Sirisanthana T, Supparatpinyo K.

J Virol Methods. 2013 Jun;190(1-2):20-8. doi: 10.1016/j.jviromet.2013.03.016. Epub 2013 Apr 3.

PMID:
23562659
17.

Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes.

Aitken SC, Kliphuis A, Wallis CL, Chu ML, Fillekes Q, Barth R, Stevens W, Rinke de Wit TF, Schuurman R.

J Clin Virol. 2012 May;54(1):21-5. doi: 10.1016/j.jcv.2012.01.010. Epub 2012 Feb 3.

PMID:
22306272
18.
19.

Identification and distribution of HIV type 1 genetic diversity and protease inhibitor resistance-associated mutations in Shanghai, P. R. China.

Zhong P, Kang L, Pan Q, Konings F, Burda S, Ma L, Xue Y, Zheng X, Jin Z, Nyambi P.

J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):91-101.

PMID:
14501800
20.

Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.

Bellocchi MC, Forbici F, Palombi L, Gori C, Coelho E, Svicher V, D'Arrigo R, Emberti-Gialloreti L, Ceffa S, Erba F, Marazzi MC, Silberstein FC, Perno CF.

J Med Virol. 2005 Aug;76(4):452-8.

PMID:
15977236

Supplemental Content

Support Center